Cargando…
Lost in the shadows: reflections on the dark side of co-production
This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-p...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204208/ https://www.ncbi.nlm.nih.gov/pubmed/32380998 http://dx.doi.org/10.1186/s12961-020-00558-0 |
_version_ | 1783530017389543424 |
---|---|
author | Williams, Oli Sarre, Sophie Papoulias, Stan Constantina Knowles, Sarah Robert, Glenn Beresford, Peter Rose, Diana Carr, Sarah Kaur, Meerat Palmer, Victoria J. |
author_facet | Williams, Oli Sarre, Sophie Papoulias, Stan Constantina Knowles, Sarah Robert, Glenn Beresford, Peter Rose, Diana Carr, Sarah Kaur, Meerat Palmer, Victoria J. |
author_sort | Williams, Oli |
collection | PubMed |
description | This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-produce health research, including highlighting various professional costs to those involved. However, we identify four related limitations in their inquiry, as follows: (1) the adoption of a problematically expansive definition of co-production that fails to acknowledge key features that distinguish co-production from broader collaboration; (2) a strong focus on technocratic rationales for co-producing research and a relative neglect of democratic rationales; (3) the transposition of legitimate concerns relating to collaboration between researchers and practitioners onto work with patients, service users and marginalised citizens; and (4) the presentation of bad practice as an inherent flaw, or indeed ‘dark side’, of co-production without attending to the corrupting influence of contextual factors within academic research that facilitate and even promote such malpractice. The Commentary’s limitations can be seen to reflect the contemporary use of the term ‘co-production’ more broadly. We describe this phenomenon as ‘cobiquity’ – an apparent appetite for participatory research practice and increased emphasis on partnership working, in combination with the related emergence of a plethora of ‘co’ words, promoting a conflation of meanings and practices from different collaborative traditions. This phenomenon commonly leads to a misappropriation of the term ‘co-production’. Our main motivation is to address this imprecision and the detrimental impact it has on efforts to enable co-production with marginalised and disadvantaged groups. We conclude that Oliver et al. stray too close to ‘the problem’ of ‘co-production’ seeing only the dark side rather than what is casting the shadows. We warn against such a restricted view and argue for greater scrutiny of the structural factors that largely explain academia’s failure to accommodate and promote the egalitarian and utilitarian potential of co-produced research. |
format | Online Article Text |
id | pubmed-7204208 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72042082020-05-12 Lost in the shadows: reflections on the dark side of co-production Williams, Oli Sarre, Sophie Papoulias, Stan Constantina Knowles, Sarah Robert, Glenn Beresford, Peter Rose, Diana Carr, Sarah Kaur, Meerat Palmer, Victoria J. Health Res Policy Syst Commentary This article is a response to Oliver et al.’s Commentary ‘The dark side of coproduction: do the costs outweigh the benefits for health research?’ recently published in Health Research Policy and Systems (2019, 17:33). The original commentary raises some important questions about how and when to co-produce health research, including highlighting various professional costs to those involved. However, we identify four related limitations in their inquiry, as follows: (1) the adoption of a problematically expansive definition of co-production that fails to acknowledge key features that distinguish co-production from broader collaboration; (2) a strong focus on technocratic rationales for co-producing research and a relative neglect of democratic rationales; (3) the transposition of legitimate concerns relating to collaboration between researchers and practitioners onto work with patients, service users and marginalised citizens; and (4) the presentation of bad practice as an inherent flaw, or indeed ‘dark side’, of co-production without attending to the corrupting influence of contextual factors within academic research that facilitate and even promote such malpractice. The Commentary’s limitations can be seen to reflect the contemporary use of the term ‘co-production’ more broadly. We describe this phenomenon as ‘cobiquity’ – an apparent appetite for participatory research practice and increased emphasis on partnership working, in combination with the related emergence of a plethora of ‘co’ words, promoting a conflation of meanings and practices from different collaborative traditions. This phenomenon commonly leads to a misappropriation of the term ‘co-production’. Our main motivation is to address this imprecision and the detrimental impact it has on efforts to enable co-production with marginalised and disadvantaged groups. We conclude that Oliver et al. stray too close to ‘the problem’ of ‘co-production’ seeing only the dark side rather than what is casting the shadows. We warn against such a restricted view and argue for greater scrutiny of the structural factors that largely explain academia’s failure to accommodate and promote the egalitarian and utilitarian potential of co-produced research. BioMed Central 2020-05-07 /pmc/articles/PMC7204208/ /pubmed/32380998 http://dx.doi.org/10.1186/s12961-020-00558-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Williams, Oli Sarre, Sophie Papoulias, Stan Constantina Knowles, Sarah Robert, Glenn Beresford, Peter Rose, Diana Carr, Sarah Kaur, Meerat Palmer, Victoria J. Lost in the shadows: reflections on the dark side of co-production |
title | Lost in the shadows: reflections on the dark side of co-production |
title_full | Lost in the shadows: reflections on the dark side of co-production |
title_fullStr | Lost in the shadows: reflections on the dark side of co-production |
title_full_unstemmed | Lost in the shadows: reflections on the dark side of co-production |
title_short | Lost in the shadows: reflections on the dark side of co-production |
title_sort | lost in the shadows: reflections on the dark side of co-production |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204208/ https://www.ncbi.nlm.nih.gov/pubmed/32380998 http://dx.doi.org/10.1186/s12961-020-00558-0 |
work_keys_str_mv | AT williamsoli lostintheshadowsreflectionsonthedarksideofcoproduction AT sarresophie lostintheshadowsreflectionsonthedarksideofcoproduction AT papouliasstanconstantina lostintheshadowsreflectionsonthedarksideofcoproduction AT knowlessarah lostintheshadowsreflectionsonthedarksideofcoproduction AT robertglenn lostintheshadowsreflectionsonthedarksideofcoproduction AT beresfordpeter lostintheshadowsreflectionsonthedarksideofcoproduction AT rosediana lostintheshadowsreflectionsonthedarksideofcoproduction AT carrsarah lostintheshadowsreflectionsonthedarksideofcoproduction AT kaurmeerat lostintheshadowsreflectionsonthedarksideofcoproduction AT palmervictoriaj lostintheshadowsreflectionsonthedarksideofcoproduction |